Seeing Is Believing
DSGN is currently covered by 2 analysts with an average price target of $14. This is a potential upside of $1.76 (14.38%) from yesterday's end of day stock price of $12.24.
Design Therapeutics's activity chart (see below) currently has 27 price targets and 29 ratings on display. The stock rating distribution of DSGN is 75% HOLD and 25% BUY.
Analysts average stock forecasts to be materialized ratio is 43.54% with an average time for these price targets to be met of 312 days.
Highest price target for DSGN is $14, Lowest price target is $14, average price target is $14.
Most recent stock forecast was given by LEONID TIMASHEV from RBC on 10-Mar-2026. First documented stock forecast 20-Apr-2021.
Currently out of the existing stock ratings of DSGN, 3 are a HOLD (75%), 1 are a BUY (25%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Mar-2026
$14
$1.88 (15.51%)
$13
6 months 22 days ago
(10-Mar-2026)
6/9 (66.67%)
$4.01 (40.14%)
153
Hold Since 03-Dec-2025
$14
$1.88 (15.51%)
9 months 29 days ago
(03-Dec-2025)
1/3 (33.33%)
$4.23 (43.30%)
147
Hold Since 07-May-2024
$12
$-0.12 (-0.99%)
2 years 4 months 25 days ago
(07-May-2024)
1/4 (25%)
$7.31 (155.86%)
699
Hold Since 14-Nov-2023
$5
$-7.12 (-58.75%)
$6
2 years 10 months 18 days ago
(14-Nov-2023)
3/6 (50%)
$2.71 (118.34%)
247
What is DSGN (Design Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on DSGN (Design Therapeutics)?
Which analyst has the most public recommendations on DSGN (Design Therapeutics)?
Which analyst is the currently most bullish on DSGN (Design Therapeutics)?
Which analyst is the currently most reserved on DSGN (Design Therapeutics)?